Advertisement
Brief report| Volume 22, ISSUE 10, P1274-1276, October 1987

Captopril as an antidepressant: Lack of effect in animal models of serotonergic function

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Callender JS
        • Hodsman GP
        • Hutcheson MJ
        • Lever AG
        • Robertson JI
        A double-blind pilot study.
        Hypertension. 1983; 5: III90-III93
        • Deiken RF
        Captopril treatment of depression.
        Biol Psychiatry. 1986; 21: 1425-1428
        • Frances H
        • Simon P
        The effect of a beta-adrenergic agonist on behaviors mediated by 5-HTIA and 5-HTIB receptors.
        Biol Psychiatry. 1986; 21: 1072-1075
        • Goodwin GM
        • Green AR
        • Johnson P
        5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice.
        Br J Pharmacol. 1984; 83: 235-242
        • Goodwin GM
        • De Souza RJ
        • Green AR
        The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT): A model of presynaptic 5-HT1 function.
        Neuropharmacology. 1985; 24: 1187-1194
        • Goodwin GM
        • De Souza RJ
        • Green AR
        Anti-depressant drugs and ECS attenuate a presynaptic 5-HT1 receptor-mediated response in mice.
        Nature. 1985; 317: 531-533
        • Grahame-Smith DG
        • Green AR
        The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
        Br J Pharmacol. 1974; 52: 19-26
        • Grahame-Smith DG
        • Green AR
        • Costain DW
        Mechanisms of the antidepressant action of electroconvulsive therapy.
        Lancet. 1978; i: 254-256
        • Green AR
        • Johnson P
        • Mountford JA
        • Nimgaonkar VL
        Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock: Implications for antidepressant therapy.
        Br J Pharmacol. 1985; 84: 337-346
        • Metz A
        • Goodwin GM
        • Green AR
        The administration of baclofen to mice increases 5-HT2-mediated headtwitch behaviour and 5-HT2 receptor number in frontal cortex.
        Neuropharmacology. 1985; 24: 357-360
        • Naylor GJ
        Vanadium and the sodium pump in manic depressive psychosis.
        in: Deakin JFW The Biology of Depression. The Royal College of Psychiatrists, London1986: 137-152 (Gaskell)
        • Singleton C
        • Marsden CA
        Increased responsiveness to 5-methoxy-N,N-dimethyltryptamine in mice on a high tryptophan diet.
        Neuropharmacology. 1979; 18: 569-572
        • Zubenko GS
        • Nixon RA
        Mood elevating effect of captopril in depressed patients.
        Am J Psychiatry. 1984; 141: 110-111